AETHLON MEDICAL, INC. Accumulated Other Comprehensive Income
AETHLON MEDICAL, INC. (AEMD) had Accumulated Other Comprehensive Income of -$38.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$38.89K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$32.70K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$29.84K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$26.38K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$38.89K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$32.70K 10-Q · filed 2026-08-13 |
| 2025-12-31 | -$29.84K 10-Q · filed 2026-02-12 |
| 2025-09-30 | -$26.38K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$22.38K 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$17.13K 10-K · filed 2026-06-10 |
| 2024-12-31 | -$17.03K 10-Q · filed 2025-02-12 |
| 2024-09-30 | -$3.97K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$7.77K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$6.94K 10-K · filed 2025-06-26 |
| 2023-12-31 | -$1.62K 10-Q · filed 2024-02-14 |
| 2023-09-30 | -$9.57K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$7.13K 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$6.14K 10-K · filed 2024-06-27 |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |